Literature DB >> 32959519

Dietary Methionine Restriction Signals to the Brain Through Fibroblast Growth Factor 21 to Regulate Energy Balance and Remodeling of Adipose Tissue.

Laura A Forney1,2, Han Fang1, Landon C Sims1, Kirsten P Stone1, Leighann Y Vincik1, Alicia M Vick1, Amanda N Gibson, David H Burk1, Thomas W Gettys1.   

Abstract

OBJECTIVE: Restricting dietary methionine to 0.17% in mice increases energy expenditure (EE), reduces fat deposition, and improves metabolic health by increasing hepatic fibroblast growth factor 21 (FGF21). The goal of this study was to compare each of these responses in mice with the coreceptor for FGF21 deleted in either adipose tissue or the brain.
METHODS: Methionine-restriction (MR) diets were fed to age-matched cohorts of mice with the coreceptor for FGF21 deleted in either adipose tissue or the brain. The physiological and transcriptional responses to MR were compared in the respective cohorts.
RESULTS: Tissue-specific deletion of the FGF21 coreceptor in adipose tissue did not abrogate the ability of dietary MR to increase  EE and reduce fat deposition. Tissue-specific deletion of the FGF21 coreceptor from the brain produced mice that were unable to respond to the effects of MR on  EE or the remodeling of adipose tissue.
CONCLUSIONS: The increase in FGF21 produced by dietary MR acts primarily in the brain to produce its physiological effects on energy balance. In contrast, the effects of MR on hepatic gene expression were intact in both models, supporting a mechanism that directly links detection of reduced methionine in the liver to transcriptional mechanisms that alter gene expression in the liver.
© 2020 The Obesity Society.

Entities:  

Year:  2020        PMID: 32959519      PMCID: PMC7513464          DOI: 10.1002/oby.22919

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  41 in total

1.  A CamKIIalpha iCre BAC allows brain-specific gene inactivation.

Authors:  E Casanova; S Fehsenfeld; T Mantamadiotis; T Lemberger; E Greiner; A F Stewart; G Schütz
Journal:  Genesis       Date:  2001-09       Impact factor: 2.487

2.  FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting.

Authors:  Qingning Liang; Ling Zhong; Jialiang Zhang; Yu Wang; Stefan R Bornstein; Chris R Triggle; Hong Ding; Karen S L Lam; Aimin Xu
Journal:  Diabetes       Date:  2014-07-14       Impact factor: 9.461

Review 3.  Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.

Authors:  Bo Angelin; Tobias E Larsson; Mats Rudling
Journal:  Cell Metab       Date:  2012-12-05       Impact factor: 27.287

4.  UCP1 is an essential mediator of the effects of methionine restriction on energy balance but not insulin sensitivity.

Authors:  Desiree Wanders; David H Burk; Cory C Cortez; Nancy T Van; Kirsten P Stone; Mollye Baker; Tamra Mendoza; Randall L Mynatt; Thomas W Gettys
Journal:  FASEB J       Date:  2015-03-05       Impact factor: 5.191

5.  Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.

Authors:  Jing Xu; Shanaka Stanislaus; Narumol Chinookoswong; Yvonne Y Lau; Todd Hager; Jennifer Patel; Hongfei Ge; Jen Weiszmann; Shu-Chen Lu; Melissa Graham; Jim Busby; Randy Hecht; Yue-Sheng Li; Yang Li; Richard Lindberg; Murielle M Véniant
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-25       Impact factor: 4.310

6.  Fibroblast growth factor 21 corrects obesity in mice.

Authors:  Tamer Coskun; Holly A Bina; Michael A Schneider; James D Dunbar; Charlie C Hu; Yanyun Chen; David E Moller; Alexei Kharitonenkov
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

7.  Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.

Authors:  Zhuofeng Lin; Haishan Tian; Karen S L Lam; Shaoqiang Lin; Ruby C L Hoo; Morichika Konishi; Nobuyuki Itoh; Yu Wang; Stefan R Bornstein; Aimin Xu; Xiaokun Li
Journal:  Cell Metab       Date:  2013-05-07       Impact factor: 27.287

8.  Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone density.

Authors:  Gene P Ables; Carmen E Perrone; David Orentreich; Norman Orentreich
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

9.  Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.

Authors:  Jing Xu; David J Lloyd; Clarence Hale; Shanaka Stanislaus; Michelle Chen; Glenn Sivits; Steven Vonderfecht; Randy Hecht; Yue-Sheng Li; Richard A Lindberg; Jin-Long Chen; Dae Young Jung; Zhiyou Zhang; Hwi-Jin Ko; Jason K Kim; Murielle M Véniant
Journal:  Diabetes       Date:  2008-10-07       Impact factor: 9.461

10.  Neuronal SIRT1 regulates macronutrient-based diet selection through FGF21 and oxytocin signalling in mice.

Authors:  Sho Matsui; Tsutomu Sasaki; Daisuke Kohno; Keisuke Yaku; Ayumu Inutsuka; Hiromi Yokota-Hashimoto; Osamu Kikuchi; Takayoshi Suga; Masaki Kobayashi; Akihiro Yamanaka; Akihiro Harada; Takashi Nakagawa; Tatsushi Onaka; Tadahiro Kitamura
Journal:  Nat Commun       Date:  2018-11-02       Impact factor: 14.919

View more
  10 in total

Review 1.  Nutrition, longevity and disease: From molecular mechanisms to interventions.

Authors:  Valter D Longo; Rozalyn M Anderson
Journal:  Cell       Date:  2022-04-28       Impact factor: 66.850

2.  The Role of Reduced Methionine in Mediating the Metabolic Responses to Protein Restriction Using Different Sources of Protein.

Authors:  Han Fang; Kirsten P Stone; Sujoy Ghosh; Laura A Forney; Thomas W Gettys
Journal:  Nutrients       Date:  2021-07-29       Impact factor: 6.706

3.  The regulation of healthspan and lifespan by dietary amino acids.

Authors:  Reji Babygirija; Dudley W Lamming
Journal:  Transl Med Aging       Date:  2021-05-24

4.  The acute transcriptional responses to dietary methionine restriction are triggered by inhibition of ternary complex formation and linked to Erk1/2, mTOR, and ATF4.

Authors:  Kirsten P Stone; Sujoy Ghosh; Jean Paul Kovalik; Manda Orgeron; Desiree Wanders; Landon C Sims; Thomas W Gettys
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379

Review 5.  Nutritional Regulation of Hepatic FGF21 by Dietary Restriction of Methionine.

Authors:  Han Fang; Kirsten P Stone; Laura A Forney; Desiree Wanders; Thomas W Gettys
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-30       Impact factor: 6.055

Review 6.  Protein Appetite at the Interface between Nutrient Sensing and Physiological Homeostasis.

Authors:  Md Shahjalal Khan; Redin A Spann; Heike Münzberg; Sangho Yu; Vance L Albaugh; Yanlin He; Hans-Rudolf Berthoud; Christopher D Morrison
Journal:  Nutrients       Date:  2021-11-16       Impact factor: 5.717

7.  Rates of protein synthesis are maintained in brain but reduced in skeletal muscle during dietary sulfur amino acid restriction.

Authors:  Wenceslao Martinez; Qian Zhang; Melissa A Linden; Nate Schacher; Sanna Darvish; Emily T Mirek; Jordan L Levy; William O Jonsson; Tracy G Anthony; Karyn L Hamilton
Journal:  Front Aging       Date:  2022-08-24

8.  Implementation of dietary methionine restriction using casein after selective, oxidative deletion of methionine.

Authors:  Han Fang; Kirsten P Stone; Laura A Forney; Landon C Sims; Gabriela C Gutierrez; Sujoy Ghosh; Thomas W Gettys
Journal:  iScience       Date:  2021-04-24

9.  Hepatic Nfe2l2 Is Not an Essential Mediator of the Metabolic Phenotype Produced by Dietary Methionine Restriction.

Authors:  Han Fang; Kirsten P Stone; Sujoy Ghosh; Laura A Forney; Landon C Sims; LeighAnn Vincik; Thomas W Gettys
Journal:  Nutrients       Date:  2021-05-24       Impact factor: 6.706

Review 10.  The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model.

Authors:  Redin A Spann; Christopher D Morrison; Laura J den Hartigh
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-03       Impact factor: 6.055

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.